Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 887,430 | 549,360 | 551,600 | 573,310 |
| Marketable Securities | N/A | 470,120 | 307,940 | 287,570 | 87,840 |
| Receivables | N/A | 1,395,640 | 1,167,090 | 1,043,580 | 988,130 |
| Inventories | N/A | 1,659,680 | 1,411,200 | 1,299,590 | 1,196,220 |
| Other current assets | 198,970 | 58,690 | 64,690 | 84,180 | 118,580 |
| TOTAL | $198,970 | $4,471,560 | $3,500,280 | $3,266,520 | $2,964,080 |
| Non-Current Assets | |||||
| PPE Net | N/A | 3,607,320 | 3,418,800 | 3,330,140 | 2,932,350 |
| Investments And Advances | 43,730 | 92,000 | 132,380 | 154,640 | 147,460 |
| Other Non-Current Assets | 527,550 | 611,600 | 456,780 | 256,000 | 207,400 |
| TOTAL | $571,280 | $4,310,920 | $4,007,960 | $3,740,780 | $3,287,210 |
| Total Assets | $770,250 | $8,782,500 | $7,508,250 | $7,007,320 | $6,251,310 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 449,350 | 358,240 | 287,610 | 250,500 | 177,180 |
| Accrued Expenses | 111,690 | 170,930 | 132,380 | 112,890 | 105,370 |
| Other current liabilities | 1,728,870 | 1,354,240 | 1,229,590 | 1,162,480 | 848,520 |
| TOTAL | $2,552,700 | $1,957,940 | $1,706,370 | $1,767,020 | $1,215,760 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 176,820 | 197,230 | 208,410 | 198,390 |
| aiOther Non-Current Liabilities | 252,550 | 294,580 | 208,480 | 108,710 | 101,530 |
| TOTAL | $726,130 | $903,060 | $741,370 | $625,400 | $609,370 |
| Total Liabilities | $3,278,830 | $2,861,010 | $2,447,760 | $2,392,440 | $1,825,140 |
| Shareholders' Equity | |||||
| Common Shares | 124,890 | 119,040 | 113,230 | 118,400 | 118,400 |
| Retained earnings | N/A | 5,641,620 | 4,840,080 | 4,502,650 | 3,786,050 |
| Other shareholders' equity | -209,330 | 165,820 | 114,180 | 3,820 | 101,360 |
| TOTAL | $-89,440 | $5,921,480 | $5,060,490 | $4,614,870 | $4,426,160 |
| Total Liabilities And Equity | $3,189,390 | $8,782,490 | $7,508,250 | $7,007,310 | $6,251,300 |